These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28694540)

  • 21. Magnesium Sulfate and Novel Therapies to Promote Neuroprotection.
    Jameson RA; Bernstein HB
    Clin Perinatol; 2019 Jun; 46(2):187-201. PubMed ID: 31010555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Need for resuscitation in preterm neonates less than 32 weeks treated with antenatal magnesium sulphate for neuroprotection].
    Lloreda-Garcia JM; Lorente-Nicolás A; Bermejo-Costa F; Martínez-Uriarte J; López-Pérez R
    Rev Chil Pediatr; 2016; 87(4):261-7. PubMed ID: 26778008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
    Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand.
    Bain E; Bubner T; Ashwood P; Crowther CA; Middleton P;
    Aust N Z J Obstet Gynaecol; 2013 Feb; 53(1):86-9. PubMed ID: 23106226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnesium sulfate for preterm neuroprotection.
    Ananth CV; Vintzileos AM
    JAMA; 2004 Feb; 291(8):940; author reply 941. PubMed ID: 14982907
    [No Abstract]   [Full Text] [Related]  

  • 26. Magnesium sulphate for fetal neuroprotection.
    Costa Fda S; Lopes L; Brennecke S
    Rev Bras Ginecol Obstet; 2011 Jun; 33(6):265-70. PubMed ID: 21877014
    [No Abstract]   [Full Text] [Related]  

  • 27. Protection of brain development by antenatal magnesium sulphate for infants born preterm.
    Chollat C; Sentilhes L; Marret S
    Dev Med Child Neurol; 2019 Jan; 61(1):25-30. PubMed ID: 30294845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal obesity and neuroprotective magnesium sulfate.
    McPherson J; Smiley S; Stamilio D
    Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants.
    Costantine MM; Drever N
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):351-66, xi. PubMed ID: 21575805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada.
    De Silva DA; Synnes AR; von Dadelszen P; Lee T; Bone JN; ; Magee LA
    Implement Sci; 2018 Jan; 13(1):8. PubMed ID: 29325592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Magnesium sulphate treatment decreases the risk of cerebral palsy after preterm birth].
    Wolf HT; Henriksen TB; Larsen ML; Pinborg A; Hegaard HK; Brok JS; Huusom LD
    Ugeskr Laeger; 2020 Nov; 182(47):. PubMed ID: 33215580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translating antenatal magnesium sulphate neuroprotection for infants born <28 weeks' gestation into practice: A geographical cohort study.
    Doyle LW; Spittle AJ; Olsen JE; Kwong A; Boland RA; Lee KJ; Anderson PJ; Cheong JLY;
    Aust N Z J Obstet Gynaecol; 2021 Aug; 61(4):513-518. PubMed ID: 33528040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antenatal magnesium sulfate for neuroprotection before preterm birth?
    Stanley FJ; Crowther C
    N Engl J Med; 2008 Aug; 359(9):962-4. PubMed ID: 18753653
    [No Abstract]   [Full Text] [Related]  

  • 34. Antenatal magnesium sulfate: Neuro-protection for preterm infants.
    Oddie S; Tuffnell DJ; McGuire W
    Arch Dis Child Fetal Neonatal Ed; 2015 Nov; 100(6):F553-7. PubMed ID: 25896966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada.
    Teela KC; De Silva DA; Chapman K; Synnes AR; Sawchuck D; Basso M; Liston RM; von Dadelszen P; Magee LA;
    BMC Pregnancy Childbirth; 2015 Dec; 15():347. PubMed ID: 26694323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ
    Am J Obstet Gynecol; 2009 Jun; 200(6):610-2. PubMed ID: 19482114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [State of the use of magnesium sulfate for prevention of cerebral palsy in pre-term newborn in the Rouen's hospital].
    Millochau JC; Marret S; Oden S; Verspyck E
    Gynecol Obstet Fertil; 2016; 44(7-8):446-9. PubMed ID: 27426688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gynecology/Obstetrics. Magnesium sulfate for fetal neuroprotection in preterm delivery. Latest advances in contraception.].
    Irion O; Julen O; Dubuisson JB; Yaron M; Lourenço AG
    Rev Med Suisse; 2011 Jan; 7(278):117-20. PubMed ID: 21400942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium sulfate during anticipated preterm birth for infant neuroprotection.
    Merrill L
    Nurs Womens Health; 2013; 17(1):42-51. PubMed ID: 23399012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the pharmacological use of intravenous magnesium before preterm cerebroprotective or deleterious for premature infants? Possible importance of the use of magnesium sulphate.
    Durlach J; Bac P; Bara M; Guiet-Bara A
    Magnes Res; 1998 Dec; 11(4):323-5. PubMed ID: 9884990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.